New Consultation: NENC NICE TAs October 2025

The North East and North Cumbria (NENC) Medicines Committee are seeking system-wide views on adoption of the proposed NICE technology appraisals published in October 2025.

This consultation is open for 4 weeks and closes at 5pm on Monday 8th December 2025. Visit the consultation page here.


New Consultation: NENC Antipsychotics – Safe Prescribing guideline

The North East and North Cumbria (NENC) Clinical Guidelines & Pathways Group are seeking system-wide views on adoption of the proposed guideline in the attached consultation document.

This consultation closes at 5pm on Monday 8th December 2025. Visit the consultation page here.


New Consultation: NENC Guideline for the Recognition and Management of Faltering Growth in Infants and Young Children

The North East and North Cumbria (NENC) Clinical Guidelines & Pathways Group are seeking system-wide views on adoption of the proposed guideline in the attached consultation document.

This consultation closes at 5pm on Wednesday 3rd December 2025. Visit the consultation page here.


New consultation: NENC SCG Cinacalcet for the management of complex primary hyperparathyroidism in adults

The North East and North Cumbria (NENC) Clinical Guidelines & Pathways Group are seeking system-wide views on adoption of the proposed guideline in the attached consultation document.

This consultation closes at 5pm on Wednesday 3rd December 2025. Visit the consultation page here.


New Consultation: Deprescribing considerations for adults with asthma currently prescribed theophylline

The North East and North Cumbria (NENC) Clinical Guidelines & Pathways Group are seeking system-wide views on adoption of the proposed guideline to aid deprescribing of theophylline in adults with asthma, as per the attached consultation document.

This consultation closes at 5pm on Tuesday 21st October 2025. Visit the consultation page here.


New Consultation: NENC gabapentin and pregabalin dose reduction regimen

The North East and North Cumbria (NENC) Clinical Guidelines & Pathways Group are seeking system-wide views on adoption of the draft NENC gabapentin and pregabalin dose reduction regimens guidance in the attached consultation document.

This consultation closes at 5pm on Wednesday 15th October 2025. Visit the consultation page here.


New Consultation: NENC NICE TAs August 2025

The North East and North Cumbria (NENC) Medicines Committee are seeking system-wide views on adoption of the proposed NICE technology appraisals.

This consultation is open for 4 weeks and closes at 5pm on Monday 13th October 2025. Visit the consultation page here.


New Consultation: NENC spirometry competency framework – Children & young people

The North East and North Cumbria (NENC) CEG and NTAG are seeking system-wide views on adoption of the proposed NENC spirometry competency framework – Children & young people in the attached consultation document.

This consultation closes at 5pm on Tuesday 7th October 2025. Visit the consultation page here.


New Consultation: NENC / NCA MALE AND REGISTERED MALE AT BIRTH BREAST SYMPTOMS PATHWAY

The NENC Clinical Guidelines & Pathways and NTAG are seeking system-wide views on adoption of the proposed draft NENC/NCA MALE AND REGISTERED MALE AT BIRTH BREAST SYMPTOMS PATHWAY.

This consultation is open for 4 weeks and closes at 5pm on Tuesday 30th September 2025. Visit the consultation page here.


New Consultation: 30-day TAs – NICE TA1094 & TA1095: Guselkumab for treating moderately to severely active ulcerative colitis / Crohn’s disease

The North East and North Cumbria (NENC) Medicines Committee are seeking system-wide views on adoption of the proposed NICE technology appraisals.

This consultation is open for 2 weeks and closes at 5pm on Monday 15th September 2025. Visit the consultation page here.